| scholarly article | Q13442814 |
| P2093 | author name string | Yong Huang | |
| Peter W Hunt | |||
| Alexander Louie | |||
| Qiyun Yang | |||
| Winnie Gee | |||
| Connie Xu | |||
| Nicholas Massenkoff | |||
| P2860 | cites work | The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells | Q28744405 |
| Generic approach to validation of small-molecule LC-MS/MS biomarker assays | Q33748826 | ||
| Endogenous kynurenines as targets for drug discovery and development | Q34156448 | ||
| Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease | Q34555620 | ||
| Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. | Q34655953 | ||
| How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation. | Q36789448 | ||
| Indoleamine-2, 3-dioxygenase and other interferon-gamma-mediated pathways in patients with human immunodeficiency virus infection | Q36789452 | ||
| Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays | Q36801534 | ||
| Quantitative profiling of tryptophan metabolites in serum, urine, and cell culture supernatants by liquid chromatography-tandem mass spectrometry | Q39461017 | ||
| Simultaneous measurement of tryptophan and related compounds by liquid chromatography/electrospray ionization tandem mass spectrometry | Q39994236 | ||
| Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques | Q43699872 | ||
| More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. | Q43893230 | ||
| Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection | Q44128933 | ||
| Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application | Q44208340 | ||
| Quantitation of endogenous analytes in biofluid without a true blank matrix | Q44638305 | ||
| Simultaneous determination of tryptophan and kynurenine in plasma samples of children patients with Kawasaki disease by high-performance liquid chromatography with programmed wavelength ultraviolet detection. | Q46036985 | ||
| Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry | Q46065776 | ||
| A proposal for comparing methods of quantitative analysis of endogenous compounds in biological systems by using the relative lower limit of quantification (rLLOQ). | Q46096351 | ||
| Plasma tryptophan, kynurenine and 3-hydroxykynurenine measurement using automated on-line solid-phase extraction HPLC-tandem mass spectrometry. | Q46131757 | ||
| Matrix effect and recovery terminology issues in regulated drug bioanalysis | Q46828138 | ||
| Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. | Q47636202 | ||
| Development and validation of a single analytical method for the determination of tryptophan, and its kynurenine metabolites in rat plasma. | Q48679497 | ||
| Fit-for-purpose method development and validation for successful biomarker measurement. | Q50743553 | ||
| Simultaneous measurement of serum tryptophan and kynurenine by HPLC | Q61906305 | ||
| Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a | Q73692306 | ||
| Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients | Q74468910 | ||
| Simultaneous determination of tryptophan, kynurenine and 5-hydroxytryptamine by HPLC: Application in uremic patients undergoing hemodialysis | Q82531240 | ||
| Simultaneous determination of urinary tryptophan, tryptophan-related metabolites and creatinine by high performance liquid chromatography with ultraviolet and fluorimetric detection | Q84797579 | ||
| Quantitation of SR 27417 in human plasma using electrospray liquid chromatography-tandem mass spectrometry: A study of ion suppression | Q86676053 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| P304 | page(s) | 1397-1407 | |
| P577 | publication date | 2013-06-01 | |
| P1433 | published in | Bioanalysis | Q18616741 |
| P1476 | title | A simple LC-MS/MS method for determination of kynurenine and tryptophan concentrations in human plasma from HIV-infected patients | |
| P478 | volume | 5 |
| Q55009853 | Adaptive NKG2C+CD57+ Natural Killer Cell and Tim-3 Expression During Viral Infections. |
| Q37317771 | Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection |
| Q36219873 | CD4/CD8 Ratio and KT Ratio Predict Yellow Fever Vaccine Immunogenicity in HIV-Infected Patients |
| Q39356675 | Chromatographic analysis of tryptophan metabolites. |
| Q41522736 | Daily Rhythm in Plasma N-acetyltryptamine. |
| Q59797360 | Determination of Tryptophan and Its Major Metabolites in Fluid from the Anterior Chamber of the Eye in Diabetic Patients with Cataract by Liquid Chromotography Mass Spectrometry (LC-MS/MS) |
| Q90380130 | Development and Validation of a Hydrophilic Interaction Liquid Chromatography Tandem Mass Spectrometry Method for the Determination of Asparagine in Human Serum |
| Q36033944 | Development of simultaneous analysis of tryptophan metabolites in serum and gastric juice - an investigation towards establishing a biomarker test for gastric cancer diagnosis |
| Q58700642 | Enrichment of gut-derived Fusobacterium is associated with suboptimal immune recovery in HIV-infected individuals |
| Q89286789 | Gentiopicroside abrogates lipopolysaccharide-induced depressive-like behavior in mice through tryptophan-degrading pathway |
| Q35648710 | Gut epithelial barrier and systemic inflammation during chronic HIV infection |
| Q34315572 | Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection |
| Q41920878 | HIV/Human herpesvirus co-infections: Impact on tryptophan-kynurenine pathway and immune reconstitution |
| Q91868236 | High Kynurenine:Tryptophan Ratio Is Associated With Liver Fibrosis in HIV-Monoinfected and HIV/Hepatitis C Virus-Coinfected Women |
| Q37047893 | Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans |
| Q54231167 | Mass spectrometric measurement of urinary kynurenine-to-tryptophan ratio in children with and without urinary tract infection. |
| Q41920092 | Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected Patients |
| Q37699665 | Potential mechanisms of effects of serum-derived bovine immunoglobulin/protein isolate therapy in patients with diarrhea-predominant irritable bowel syndrome |
| Q57181096 | Simultaneous determination of tryptophan and its 31 catabolites in mouse tissues by polarity switching UHPLC-SRM-MS |
| Q99551285 | Solvent front position extraction with semi-automatic device as a powerful sample preparation procedure to quantitatitation of tryptophan in human plasma |
| Q36167122 | The Kynurenine Pathway of Tryptophan Catabolism and AIDS-Associated Kaposi Sarcoma in Africa |
| Q34106235 | The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy |
| Q92058253 | Tryptophan Metabolism Activates Aryl Hydrocarbon Receptor-Mediated Pathway To Promote HIV-1 Infection and Reactivation |
| Q64112615 | Ultrahigh-Performance Liquid Chromatography Tandem Mass Spectrometry with Electrospray Ionization Quantification of Tryptophan Metabolites and Markers of Gut Health in Serum and Plasma-Application to Clinical and Epidemiology Cohorts |
Search more.